Back to ACET

JOHNSON & JOHNSON → ACET

JOHNSON & JOHNSON ACET Position History

Adicet Bio, Inc.

Quarters held
7
Latest value
$163K
Q3 2026
Peak value
$295K
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$295K
Q3 2025$295K
Q4 2025$192K
Q4 2025$192K
Q1 2026$155K
Q2 2026$197K
Q3 2026$163K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$163K22.8K——
Q2 2026$197K22.8K——
Q1 2026$155K22.8K——
Q4 2025$192K22.8K——
Q4 2025$192K22.8K——
Q3 2025$295K364.5K——
Q3 2025$295K364.5K——

Other funds holding ACET

Other JOHNSON & JOHNSON positions

PB

PROTAGONIST THERAPEUTICS INC

$345.1M
PB

PROTAGONIST THERAPEUTICS INC

$300.2M
PB

Protagonist Therapeutics Inc.

$258.1M
PB

Protagonist Therapeutics Inc.

$213.9M
PB

Protagonist Therapeutics Inc.

$213.9M
NNBXF

NANOBIOTIX

$212M
NNBXF

NANOBIOTIX

$175.2M
NNBXF

Nanobiotix S.A.

$173.6M